Randomized trial examines PrEP acceptance in drug-involved couples, highlighting the role of gender and risk perception.
People under community supervision who use drugs face elevated HIV risk. This randomized controlled trial used a mixed-methods approach to examine PrEP acceptance among community-supervised men who use drugs and their female partners. The study evaluated PrEP willingness among participants ( N = 394) randomized to either PACT (5-session couples’ HIV intervention) or control (1-session HIV counseling). Qualitative interviews with 20 couples ( n = 40) explored PrEP attitudes. The PACT group showed significantly higher intentions to use condoms with PrEP compared to controls (64% vs. 53%, p = 0.03). Female partners in the PACT intervention demonstrated stronger PrEP use intentions than females in the control (aOR = 2.85, p = 0.02). Qualitative findings revealed five key factors affecting PrEP acceptance: (1) partner infidelity concerns, (2) substance use and decision-making, (3) HIV acquisition fears, (4) low-risk perception despite objective risk factors, and (5) medical mistrust. Gender influences PrEP acceptance among criminal legal-involved couples. Effective interventions should address gender differences, risk perception disparities, and medical mistrust. Trial registration ClinicalTrials.gov NCT01690494 registered September 19, 2012.
No takes yet. Share an insight, caveat, or question.
Goddard‐Eckrich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: